Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
40.42
-0.03 (-0.07%)
Sep 14, 2026, 4:00 PM EDT

SHE:301108 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
86.3877.2719.46115.2140.97220.05
Depreciation & Amortization
56.3150.9146.7539.0634.4130.81
Other Amortization
5.843.680.950.12--
Loss (Gain) From Sale of Assets
-0.2-0.360.03-0.32-1.15-0.29
Asset Writedown & Restructuring Costs
17.9310.5517.4910.5111.460.42
Loss (Gain) From Sale of Investments
-17.56-16.44-13.31-29.13-12.93-
Provision & Write-off of Bad Debts
9.899.898.12-1.230.790.67
Other Operating Activities
24.811.31-2.63-4.98-6.745.88
Change in Accounts Receivable
-195.43-182.8821.05-29.8736.39-6.34
Change in Inventory
-9.37-20.54-13.39-6.3376.74-43.14
Change in Accounts Payable
278.5175.8-26.87-10.84-46.66-12.36
Change in Other Net Operating Assets
-22.89-11.8413.69-1.6865.52-3.26
Operating Cash Flow
220.8899.1775.1283.51299.02200.18
Operating Cash Flow Growth
-32.02%-10.05%-72.07%49.38%6.73%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-251.29-367.95-96.23-85.05-29.91-72.59
Sale of Property, Plant & Equipment
1.622.750.620.380.350.12
Investment in Securities
-77.49478.96-211.12-311.78-570-
Other Investing Activities
9.9246.6836.184.842.99-5
Investing Cash Flow
-317.23160.44-270.56-391.61-596.57-77.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-5.71----
Long-Term Debt Repaid
--9.43-10.54-7.83--45
Lease Payments
-9.43-9.43-10.54-7.83--
Net Debt Issued (Repaid)
99.45-3.72-10.54-7.83--45
Issuance of Common Stock
-----1,056
Repurchase of Common Stock
---20.06---
Common Dividends Paid
-37.58-19.3-29.16-40.6-60.91-0.26
Other Financing Activities
-117.28-70.397.759.996.75-23.46
Financing Cash Flow
-55.41-93.4-52.01-38.45-54.16987.26

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-11.02-2.581.640.530.61-3.62
Net Cash Flow
-162.78163.63-245.81-346.02-351.111,106

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-30.4-268.78-21.11-1.54269.1127.59
Free Cash Flow Growth
----110.91%51.25%
Free Cash Flow Margin
-3.45%-34.82%-3.86%-0.25%40.37%12.96%
Free Cash Flow Per Share
-0.23-2.37-0.18-0.012.371.46
Levered Free Cash Flow
-201.33-277.68-49.34-4.2146.8214.34
Unlevered Free Cash Flow
-200.45-276.81-48.86-3.57147.9815.35
Free Cash Flow After Leases
-39.83-278.21-31.65-9.37269.1127.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
--35.44-6.779.0114.07-35.75
Change in Working Capital
37.5-47.64-1.74-45.71132.21-57.36